Microtomes Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Microtomes Market Report is Segmented by Product, Technology, End User, and Geography. The Product Segment is Divided Into Instruments and Accessories. The Technology Segment is Further Segmented Into Manual Microtomes and Automated Microtomes. The End-User Segment Includes Hospital Laboratories, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End-Users. The Geography Segment is Further Divided Into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The Report Offers the Value (USD) for the Above Segments.

Microtomes Market Size

Compare market size and growth of Global Microtomes Market with other markets in Healthcare Industry

Microtomes Market Analysis

The Global Microtomes Market size is estimated at USD 347.44 million in 2025, and is expected to reach USD 439.85 million by 2030, at a CAGR of 4.83% during the forecast period (2025-2030).

Major factors propelling the growth of the microtomes market are the increasing burden of cancer, rising demand for digital pathology, and technological advancements in the domain.

The increasing number of people with cancer is expected to be the key driving factor for the microtome market. For instance, according to January 2024 estimates of the American Cancer Society, the number of new cancer cases will ramp up from 1.9 million in 2023 to 2.0 million in 2024. The most common type of cancers diagnosed in 2023 were breast, lung, and hematological malignancies in the United States. The rising number of cancer cases can be reduced through early screening and diagnosis.

Similarly, according to a report published by La Revue du Praticien in January 2024, the incidence of cancer in metropolitan France rose, with 433,136 new cases in 2023. This underscores the growing need for precise diagnostic tools, and the heightened demand is propelling the growth of the microtomes market, driven by the increased requirement for high-quality tissue sectioning equipment.

As cancer survival rates vary significantly among tumor sites, particularly with low survival rates for pancreatic (11%), liver (18%), and lung cancers (20%), the need for advanced microtome technology to improve diagnostic accuracy and treatment planning is expanding. The rising variability in cancer survival rates across tumor sites underscores the critical need for advanced microtome technology to enhance diagnostic precision and treatment strategies, thereby driving growth in the microtome market.

Moreover, the rising demand for digital pathology is also propelling the growth of the microtomes market. Digital pathology significantly enhances diagnostic accuracy and consistency through advanced image analysis algorithms. For instance, a report published in Virchows Archiv Journal in November 2023 highlighted the growing demand for digital pathology due to advancements in high-precision, automated tissue sectioning. This technological progression supports enhanced digital imaging and analysis, driving increased interest and adoption in the field. This increased need for accuracy and efficiency in tissue processing is fueling the adoption of sophisticated microtome systems that enhance diagnostic reliability and workflow productivity, thereby propelling market growth.

According to the same source, microtomes are compatible with digital pathology workflows and are crucial to support these sophisticated analyses, as they ensure the capture of high-resolution images. Telepathology also enables remote consultations on digital slides, facilitating expert reviews, accelerating diagnostic turnaround times, and broadening access to specialized pathology expertise.

In conclusion, the growth of the microtome market is driven by the increasing cancer burden, rising demand for precise diagnostic tools, and advancements in digital pathology that enhance diagnostic accuracy and workflow efficiency.

However, the lack of access to pathology services in low-income countries and a low number of pathologists are also restraining the growth of the microtome market.

Microtomes Market Market Industry Overview

The microtomes market is competitive, with key players holding a significant share of the market. Technological advancements and product innovation are expected to provide new opportunities for companies to compete within the market. Some of the major players include Thermo Fisher Scientific Inc., Leica Biosystems, Sakura Finetek, SLEE Medical GmbH, and Histo-Line Laboratories.

Microtomes Market Leaders

  1. Thermo Fisher Scientific Inc.

  2. Leica Biosystems Nussloch GmbH

  3. Sakura Finetek

  4. SLEE medical GmbH

  5. Histo-Line Laboratories

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF

Microtomes Market News

  • April 2024: The Caring for Tomorrow Endowment Fund donated USD 919,640 to Owen Sound Hospital. The hospital plans to use the funds to purchase new microtomes for its laboratory and a cautery machine for Ambulatory Care. The hospital will also undertake various improvements, including acquiring an ultrasound unit for Interventional Radiology and a storage cabinet for radioactive materials in Nuclear Medicine.
  • February 2024: Dr. David Larbi Simpong, Senior Lecturer at the University of Cape Coast's Department of Medical Laboratory Science, donated two rotary microtomes valued at EUR 10,000 (USD 10,910). These rotary microtomes enhanced students' practical training in pathology by facilitating the processing of biological tissue for research and clinical diagnosis, especially in cancer detection.

Global Microtomes Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cancer
    • 4.2.2 Increasing Demand in Digital Pathology
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Lack of Access to Pathology Services in Low-income Countries
    • 4.3.2 Inadequate Number of Pathologists
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.1.1 Rotary Microtomes
    • 5.1.1.2 Cryostat Microtomes
    • 5.1.1.3 Vibrating Microtomes
    • 5.1.1.4 Laser Microtome
    • 5.1.1.5 Ultra Microtomes
    • 5.1.1.6 Other Products
    • 5.1.2 Accessories
  • 5.2 By Technology
    • 5.2.1 Manual Microtomes
    • 5.2.2 Automated Microtomes
  • 5.3 By End User
    • 5.3.1 Hospital Laboratories
    • 5.3.2 Clinical Laboratories
    • 5.3.3 Pharmaceutical and Biotechnology Companies
    • 5.3.4 Other End-Users
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Leica Biosystems Nussloch GmbH
    • 6.1.3 Sakura Finetek
    • 6.1.4 SLEE medical GmbH
    • 6.1.5 MEDITE Medical GmbH
    • 6.1.6 Histo-Line Laboratories
    • 6.1.7 Amos Scientific Pty Ltd
    • 6.1.8 Boeckeler Instruments Inc.
    • 6.1.9 Diapath SpA
    • 6.1.10 Brunel Microscopes Ltd
    • 6.1.11 Cardinal Health
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Microtomes Industry Segmentation

As per the scope of the report, a microtome is a device used to cut thin sections of tissues for microscopic examination, and the process is known as microtomy. The cut tissue, usually of 2 to 10-micrometer thickness, is further processed for observation under a microscope. The microtomes market is segmented by product, technology, end user, and geography. The product segment is divided into instruments and accessories. The technology segment is further segmented into manual microtomes and automated microtomes. The end-user segment includes hospital laboratories, clinical laboratories, pharmaceutical and biotechnology companies, and other end-users. The geography segment is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.

By Product Instruments Rotary Microtomes
Cryostat Microtomes
Vibrating Microtomes
Laser Microtome
Ultra Microtomes
Other Products
Accessories
By Technology Manual Microtomes
Automated Microtomes
By End User Hospital Laboratories
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other End-Users
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Global Microtomes Market Research Faqs

How big is the Global Microtomes Market?

The Global Microtomes Market size is expected to reach USD 347.44 million in 2025 and grow at a CAGR of 4.83% to reach USD 439.85 million by 2030.

What is the current Global Microtomes Market size?

In 2025, the Global Microtomes Market size is expected to reach USD 347.44 million.

Who are the key players in Global Microtomes Market?

Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmbH, Sakura Finetek, SLEE medical GmbH and Histo-Line Laboratories are the major companies operating in the Global Microtomes Market.

Which is the fastest growing region in Global Microtomes Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Microtomes Market?

In 2025, the North America accounts for the largest market share in Global Microtomes Market.

What years does this Global Microtomes Market cover, and what was the market size in 2024?

In 2024, the Global Microtomes Market size was estimated at USD 330.66 million. The report covers the Global Microtomes Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Microtomes Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Microtomes Industry Report

Statistics for the 2025 Global Microtomes market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Microtomes analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Microtomes Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)